Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 13/20 | 1.00 |
| ▸ | RARG | P13631 | 13/20 | 1.00 |
| ▸ | RARA | P10276 | 10/20 | 1.00 |
| ▸ | RXRA | P19793 | 12/20 | 0.72 |
| ▸ | CYP26A1 | O43174 | 3/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | THPO | P40225 | 1/20 | 0.68 |
| ▸ | MTOR | P42345 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1615597 | 1.00 | RARB (1.00) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL1615595 | 1.00 | RARB (1.00) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL9747847 | 0.89 | RARB (0.80) | RARBRARGRARARXRACYP26A1 | |
| 4-Aminophenol SCHEMBL10842256 | 0.89 | RARB (0.79) | RARBRARGRARARXRACYP26A1 | |
| 4-Aminophenol SCHEMBL10842270 | 0.89 | RARB (0.79) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL8026153 | 0.88 | RARB (0.78) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL4315172 | 0.86 | RARB (0.75) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL4315169 | 0.86 | RARB (0.75) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL1615307 | 0.85 | RARB (0.74) | RARBRARGRARARXRACYP26A1 | |
| SCHEMBL1615305 | 0.85 | RARB (0.74) | RARBRARGRARARXRACYP26A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115430166-B | Process system and method for steam driven heat pump auxiliary bulkhead tower | 天津大学 | 2024-06-21 | — | — | CN | claimed |
| CN-115430166-A | Process system and method for steam-driven heat pump auxiliary partition tower | 天津大学 | 2022-12-06 | — | — | CN | claimed |
| US-20250289443-A1 | Custom Application System for Safe Vehicle Operation | Applied Electric Vehicles Ltd (AU) | 2025-09-18 | — | — | US | disclosed |
| CN-223093570-U | Stator thread end forming module | 福建闽光电机制造有限公司 | 2025-07-11 | — | — | CN | disclosed |
| CN-119799671-A | Protein mutant and application of biological material thereof in production of L-isoleucine | 宁夏伊品生物科技股份有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119692916-A | Material shipment method, system and terminal equipment | 深圳市金合联技术股份有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-119506345-A | Application of alfalfa VIK protein in cultivation of phytophthora root rot resistant plants | 中国农业大学 | 2025-02-25 | — | — | CN | disclosed |
| US-20240410237-A1 | WRENCH ASSEMBLY BUMPER PLATE SYSTEMS | PATTERSON-UTI DRILLING COMPANY LLC | 2024-12-12 | — | — | US | disclosed |
| CN-115430166-B | Process system and method for steam driven heat pump auxiliary bulkhead tower | 天津大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-220889611-U | Prevent concrete cover board repair with mortar spraying equipment of breakfast | 山东高速威海发展有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-110833429-B | Computed tomography imaging method, device, equipment and storage medium | 上海联影医疗科技股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20070129368-A1 | Tricyclic hydroxamate and benzamide derivatives, compositions and methods | EXONHIT THERAPEUTICS S.A. (FR) | 2007-06-07 | — | — | US | disclosed |
| EP-1692097-A1 | TRICYCLIC HYDROXAMATE AND BENZAMIDE DERIVATIVES, COMPOSITIONS AND METHODS | Exonhit Therapeutics SA (FR) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005058803-A1 | TRICYCLIC HYDROXAMATE AND BENZAMIDE DERIVATIVES, COMPOSITIONS AND METHODS | EXONHIT THERAPEUTICS SA (FR) | 2005-06-30 | — | — | WO | disclosed |
| WO-2005058803-A1 | TRICYCLIC HYDROXAMATE AND BENZAMIDE DERIVATIVES, COMPOSITIONS AND METHODS | EXONHIT THERAPEUTICS SA (FR) | 2005-06-30 | — | — | WO | disclosed |
| EP-1541549-A1 | Tricyclic hydroxamate and benzaminde derivatives, compositions and methods | Exonhit Therapeutics S.A. (FR) | 2005-06-15 | — | — | EP | disclosed |
| WO-1999048529-A1 | RETINOID-GLITAZONE COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-09-30 | — | — | WO | disclosed |
| EP-0808159-A1 | USE OR RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024344-A1 | USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) | WARNER-LAMBERT COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| US-5489611-A | ADMINISTERING A RETINOID COMPOUND | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129368-A1 | Tricyclic hydroxamate and benzamide derivatives, compositions and methods | HDAC5, HDAC1, HDAC2 | RARB 998/4885RARG 904/4885RARA 1012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.